news

Sept. 26 2019
iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint Targets

Sept. 24 2019
Salarius Pharmaceuticals Achieves Dose-Escalation Milestones in Ongoing Phase 1/2 Ewing Sarcoma and Phase 1 Advanced Solid Tumor Clinical Trials

Sept. 23 2019
Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchekâ„¢ Prostate Cancer Study


 

events

Oct. 13-15 2019
American Neurological Association Annual Meeting

Oct. 22-23 2019
BIO Investor Forum

Oct. 25-30 2019
ACG World Congress

Nov. 6-10
SITC 2019


 

spotlight